Various inflammatory biomarkers show prognostic potential for multiple sclerosis (MS)-risk after clinically isolated syndromes. However, biomarkers are often examined singly and their interrelation and precise aspects of their associated pathological processes remain unclear. Clarification of these relationships could aid the appropriate implementation of prognostic biomarkers in clinical practice.To investigate the interrelation between biomarkers of inflammation, demyelination and neurodegeneration in acute optic neuritis and to assess their association to measures of MS risk.A prospective study at a tertiary referral centre from June 2011 to December 2012 of 56 patients with optic neuritis as a first demyelinating symptom and 27 healthy ...
Multiple Sclerosis (MS) is considered an autoimmune disease of the central nervous system (CNS). It ...
Background: Multiple sclerosis (MS) is a chronic, immune-mediated, inflammatory, neurodegenerative d...
Some recent studies suggest that in progressive multiple sclerosis, neurodegeneration may occur inde...
BACKGROUND:Various inflammatory biomarkers show prognostic potential for multiple sclerosis (MS)-ris...
Abstract Background Long-term outcome in multiple sclerosis (MS) depends on early treatment. In pati...
Inflammatory mediators have crucial roles in leukocyte recruitment and subsequent central nervous sy...
OBJECTIVE: To determine if serum inflammatory mediators can distinguish between patients with neurom...
Background: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical an...
Neuromelitis optica (NMO) is an inflammatory, demyelinating disease of the central nervous system. I...
The pathophysiology of multiple sclerosis (MS) is complex with the presence of inflammation and neur...
BACKGROUND: Differences in cytokine/chemokine profiles among patients with neuromyelitis optica (NMO...
Background: Differences in cytokine/chemokine profiles among patients with neuromyelitis optica (NMO...
For many years, quantifiable biomarkers in neurological diseases have represented a hot topic. In mu...
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). MS usually sta...
Background. Disability in multiple sclerosis (MS) is related to neuroaxonal degeneration. A reliable...
Multiple Sclerosis (MS) is considered an autoimmune disease of the central nervous system (CNS). It ...
Background: Multiple sclerosis (MS) is a chronic, immune-mediated, inflammatory, neurodegenerative d...
Some recent studies suggest that in progressive multiple sclerosis, neurodegeneration may occur inde...
BACKGROUND:Various inflammatory biomarkers show prognostic potential for multiple sclerosis (MS)-ris...
Abstract Background Long-term outcome in multiple sclerosis (MS) depends on early treatment. In pati...
Inflammatory mediators have crucial roles in leukocyte recruitment and subsequent central nervous sy...
OBJECTIVE: To determine if serum inflammatory mediators can distinguish between patients with neurom...
Background: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical an...
Neuromelitis optica (NMO) is an inflammatory, demyelinating disease of the central nervous system. I...
The pathophysiology of multiple sclerosis (MS) is complex with the presence of inflammation and neur...
BACKGROUND: Differences in cytokine/chemokine profiles among patients with neuromyelitis optica (NMO...
Background: Differences in cytokine/chemokine profiles among patients with neuromyelitis optica (NMO...
For many years, quantifiable biomarkers in neurological diseases have represented a hot topic. In mu...
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). MS usually sta...
Background. Disability in multiple sclerosis (MS) is related to neuroaxonal degeneration. A reliable...
Multiple Sclerosis (MS) is considered an autoimmune disease of the central nervous system (CNS). It ...
Background: Multiple sclerosis (MS) is a chronic, immune-mediated, inflammatory, neurodegenerative d...
Some recent studies suggest that in progressive multiple sclerosis, neurodegeneration may occur inde...